Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health Outcomes
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Hospital Benin, Congo, The Democratic Republic
Closing the Knowledge Gap in anti-TNF Cycling in Rheumatoid Arthritis
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Increasing Healthcare Professional Skills For COVID-19 Vaccine Discussions That Advocate Vaccination
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Management of Adults and Adolescents with Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Sickle Cell Disease Transition in Care
Release Date:
Partner: National Alliance of Sickle Cell Centers
Review Process: Expert Review Panel
Quality Improvement Rare Disease USA
2025 Rheumatology Fellowship – United States
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
Closing the Knowledge Gap in the Diagnosis and Management of Idiopathic Inflammatory Myopathies (IIM)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Invasive Mold Diseases (IMD) & Treatment Outcomes
Release Date:
Review Process: Pfizer Internal
Research Hospital Australia, Austria, Belgium, China, France, Germany, Greece, Italy, Korea, Netherlands, Spain, Switzerland, United Kingdom
Implementing Updated RSV Immunization Recommendations for Older Adults
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Optimization of Health IT to support RSV Immunizations
Release Date:
Review Process: Expert Review Panel
Quality Improvement Vaccines USA
Title
Grant Type
Focus Area
Country
Application Due Date
Rheumatology Education Healthcare Disparities
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Promotion of the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan
Improving Knowledge and Capability to Communicate Information on the Latest Hemophilia Treatments
Release Date:
Review Process: Pfizer Internal
Education Rare Disease Japan
Equity in Access to Cancer Cachexia Clinical Trials
Release Date:
Review Process: Pfizer Internal
Quality Improvement Internal Medicine All
Infectious Disease Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Hospital India
Inflammatory Bowel Disease (Europe, Canada, Australia, New Zealand, Japan, Israel and Turkey)
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology All
Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Mayo Clinic
Review Process: Expert Review Panel
Translation: Arabic (link)
Translation: French (link)
Translation: Mandarin (link)
Translation: Spanish (link)
Quality Improvement Rare Disease All
2022 Growth Hormone Research
Release Date:
Review Process: Pfizer Internal
Research Rare Disease All
Meta-analysis of COVID-19 Vaccine Hesitancy Behavioral & Social Science Research
Release Date:
Review Process: Pfizer Internal
Research Vaccines USA
New & Emerging Therapies for Atopic Dermatitis for Dermatologists, Allergists, and Advanced Practice Providers
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Addressing the Needs of Patients with Mental Health Issues and Inflammatory Bowel Diseases
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology Canada
Improving the Care of Patients with Disorders of Impaired Growth
Release Date:
Partner: ICOSEP
Review Process: Expert Review Panel
Quality Improvement Rare Disease All